Annual CFO
-$73.02 M
+$15.37 M+17.39%
December 31, 2023
Summary
- As of February 7, 2025, TSHA annual cash flow from operations is -$73.02 million, with the most recent change of +$15.37 million (+17.39%) on December 31, 2023.
- During the last 3 years, TSHA annual CFO has fallen by -$42.29 million (-137.62%).
- TSHA annual CFO is now -137.62% below its all-time high of -$30.73 million, reached on December 31, 2020.
Performance
TSHA Cash From Operations Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly CFO
-$21.61 M
-$111.00 K-0.52%
September 30, 2024
Summary
- As of February 7, 2025, TSHA quarterly cash flow from operations is -$21.61 million, with the most recent change of -$111.00 thousand (-0.52%) on September 30, 2024.
- Over the past year, TSHA quarterly CFO has dropped by -$3.67 million (-20.42%).
- TSHA quarterly CFO is now -246.92% below its all-time high of $14.71 million, reached on December 31, 2022.
Performance
TSHA Quarterly CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM CFO
-$79.03 M
-$3.67 M-4.86%
September 30, 2024
Summary
- As of February 7, 2025, TSHA TTM cash flow from operations is -$79.03 million, with the most recent change of -$3.67 million (-4.86%) on September 30, 2024.
- Over the past year, TSHA TTM CFO has dropped by -$36.84 million (-87.33%).
- TSHA TTM CFO is now -4551.80% below its all-time high of -$1.70 million, reached on March 31, 2020.
Performance
TSHA TTM CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash From Operations Formula
CFO = Net Income + Non Cash Expenses + Changes In Working Capital
TSHA Cash From Operations Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +17.4% | -20.4% | -87.3% |
| 3 y3 years | -137.6% | +32.3% | +18.2% |
| 5 y5 years | - | - | - |
TSHA Cash From Operations Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +37.6% | -246.9% | +47.2% | -87.3% | +46.0% |
| 5 y | 5-year | -137.6% | +37.6% | -246.9% | +47.2% | -4551.8% | +46.0% |
| alltime | all time | -137.6% | +37.6% | -246.9% | +47.2% | -4551.8% | +46.0% |
Taysha Gene Therapies Cash From Operations History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | -$21.61 M(+0.5%) | -$79.03 M(+4.9%) |
| Jun 2024 | - | -$21.50 M(+8.6%) | -$75.37 M(+3.8%) |
| Mar 2024 | - | -$19.80 M(+22.8%) | -$72.63 M(-0.5%) |
| Dec 2023 | -$73.02 M(-17.4%) | -$16.12 M(-10.2%) | -$73.02 M(+73.1%) |
| Sep 2023 | - | -$17.95 M(-4.4%) | -$42.19 M(-20.5%) |
| Jun 2023 | - | -$18.77 M(-7.0%) | -$53.05 M(-21.6%) |
| Mar 2023 | - | -$20.18 M(-237.2%) | -$67.64 M(-23.5%) |
| Dec 2022 | -$88.39 M | $14.71 M(-151.1%) | -$88.39 M(-38.3%) |
| Sep 2022 | - | -$28.81 M(-13.6%) | -$143.36 M(-2.1%) |
| Jun 2022 | - | -$33.35 M(-18.5%) | -$146.48 M(+7.8%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2022 | - | -$40.94 M(+1.7%) | -$135.95 M(+16.2%) |
| Dec 2021 | -$117.04 M(+280.9%) | -$40.26 M(+26.1%) | -$117.04 M(+21.1%) |
| Sep 2021 | - | -$31.93 M(+40.0%) | -$96.63 M(+35.3%) |
| Jun 2021 | - | -$22.82 M(+3.5%) | -$71.42 M(+39.9%) |
| Mar 2021 | - | -$22.04 M(+11.0%) | -$51.06 M(+66.2%) |
| Dec 2020 | -$30.73 M | - | - |
| Dec 2020 | - | -$19.85 M(+195.5%) | -$30.73 M(+182.4%) |
| Sep 2020 | - | -$6.72 M(+172.3%) | -$10.88 M(+161.2%) |
| Jun 2020 | - | -$2.47 M(+45.1%) | -$4.17 M(+145.1%) |
| Mar 2020 | - | -$1.70 M | -$1.70 M |
FAQ
- What is Taysha Gene Therapies annual cash flow from operations?
- What is the all time high annual CFO for Taysha Gene Therapies?
- What is Taysha Gene Therapies annual CFO year-on-year change?
- What is Taysha Gene Therapies quarterly cash flow from operations?
- What is the all time high quarterly CFO for Taysha Gene Therapies?
- What is Taysha Gene Therapies quarterly CFO year-on-year change?
- What is Taysha Gene Therapies TTM cash flow from operations?
- What is the all time high TTM CFO for Taysha Gene Therapies?
- What is Taysha Gene Therapies TTM CFO year-on-year change?
What is Taysha Gene Therapies annual cash flow from operations?
The current annual CFO of TSHA is -$73.02 M
What is the all time high annual CFO for Taysha Gene Therapies?
Taysha Gene Therapies all-time high annual cash flow from operations is -$30.73 M
What is Taysha Gene Therapies annual CFO year-on-year change?
Over the past year, TSHA annual cash flow from operations has changed by +$15.37 M (+17.39%)
What is Taysha Gene Therapies quarterly cash flow from operations?
The current quarterly CFO of TSHA is -$21.61 M
What is the all time high quarterly CFO for Taysha Gene Therapies?
Taysha Gene Therapies all-time high quarterly cash flow from operations is $14.71 M
What is Taysha Gene Therapies quarterly CFO year-on-year change?
Over the past year, TSHA quarterly cash flow from operations has changed by -$3.67 M (-20.42%)
What is Taysha Gene Therapies TTM cash flow from operations?
The current TTM CFO of TSHA is -$79.03 M
What is the all time high TTM CFO for Taysha Gene Therapies?
Taysha Gene Therapies all-time high TTM cash flow from operations is -$1.70 M
What is Taysha Gene Therapies TTM CFO year-on-year change?
Over the past year, TSHA TTM cash flow from operations has changed by -$36.84 M (-87.33%)